{"id":"W2117178293","doi":"10.1358/dot.2004.40.11.872578","title":"Efalizumab: Advancing psoriasis management with a novel, targetedT-cell modulator","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Psoriasis; Medicine; Pathogenesis; Monoclonal antibody; Immunology; Clinical trial; Monoclonal; Dermatology; Antibody; Plaque psoriasis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003006564,0.0007923865,0.002112882,0.0003983629,0.0001461937,0.00001499873,0.0005578967,0.0005957403,0.0003445562],"category_scores_gemma":[0.00001328433,0.0005777818,0.0006787325,0.0003967317,0.000125558,0.00009161801,0.0001661842,0.0002949635,0.0003024563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003479577,"about_ca_system_score_gemma":0.0003158697,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008005888,"about_ca_topic_score_gemma":0.000007887474,"domain_scores_codex":[0.9975169,0.00014794,0.0007749234,0.0007665271,0.0001421217,0.0006515971],"domain_scores_gemma":[0.9981795,0.0001297325,0.0007072454,0.000828618,0.00009950004,0.0000554336],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000125498,0.0006606398,0.000004567117,0.01914015,0.003256589,0.00004327972,0.0002594403,0.00002053885,0.00009628411,0.0006294167,0.001050805,0.9747128],"study_design_scores_gemma":[0.002938014,0.0002024772,0.00000538624,0.009789038,0.004191254,0.00005151217,0.0000906917,1.345178e-7,0.000980658,0.00002587281,0.9810862,0.0006387805],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001585588,0.9925759,0.0001360633,0.00001135569,0.0009832344,0.001147415,0.0007360142,0.0001039759,0.004147494],"genre_scores_gemma":[0.0005797456,0.9907448,0.002013124,0.00001722088,0.00006781987,0.0002566464,0.0008727997,0.0001193135,0.005328537],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9800354,"threshold_uncertainty_score":0.9996673,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01323569622806394,"score_gpt":0.2490423389269608,"score_spread":0.2358066426988968,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}